The usefulness of factor XIII levels in Crohn's disease

Journal of Crohn's and Colitis

Volumn 6, Issue 6, 2012, Pages 660-664

  Cougard, Pierre Alain ^a   Desjeux, Ariadne ^a   Vitton, Veronique ^a   Baumstarck Barrau, Karine ^b   Lesavre, Nathalie ^a   Grimaud, Jean Charles ^a  

^a HÔPITAL NORD   (France)

^b Assistance Publique HÔpitaux de Marseille ^*  (France)

Author keywords

CDAI; Crohn's disease; Crohn's disease activity; Factor XIII

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13A; C REACTIVE PROTEIN; FIBRIN;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX SCORE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SCORING SYSTEM; THROMBOCYTE COUNT;

ADULT; BIOLOGICAL MARKERS; COLONIC DISEASES, FUNCTIONAL; CROHN DISEASE; DISEASE PROGRESSION; FACTOR XIII; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84862258232     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.11.016     Document Type: Article

References (23)

1. J.McDonagh Biochemistry of fibrin stabilizing factor (FXIII). Factor XIII, 2nd International Conference Schattauer, Stuttgart, Germany 1993, 1-8. J. McDonagh, J.R. Seitz, R. Egbring (Eds.).
2. Kimura S., Aoki N. Crosslinking site in fibrinogen for α2 antiplasmine. J Biol Chem 1986, 261:15591-15595.
3. Duckert F., Jung E., Schmerling D.H. A hitherto undescribed congenital diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh 1960, 5:179-186.
4. Bernstein C.N., Shanahan F. Factor XIII: is it a factor in Crohn's disease?. Gastroenterology 1994, 106:281.
5. Clinique evaluation of pasteurized factor XIII concentrate administration in Henoch SchÔnlein purpura. Thromb Res 1989, 56:667-675. Fukui H and the Japanese Pediatric Group.
6. Chamouard P., Grunebaum L., Wiesel M.L., Sibilia J., Coumaros G., Wittersheim C., et al. Significance of diminished factor XIII in Crohn's disease. Am J Gastroenterol 1998, 93:610-614.
7. Oshitani N., Kitano A., Hara J., Suzuki N., Aoki T., Yasuda K., et al. Deficiency of blood coagulation FXIII in Crohn's disease. Am J Gastroenterol 1995, 90:1116-1118.
8. Vrij A.A., Rijken J., van Wersch J.W., Stockbrügger R.W. Differential behavior of coagulation factor XIII in patients with inflammatory bowel disease and in patients with giant cell arteritis. Haemostasis 1999, 29:326-335.
9. van Bodegraven A.A., Schoorl M., Linskens R.K., Kruishoop A. Persistent activation of coagulation and fibrinolysis after treatment of active ulcerative colitis. Eur J Gastroenterol Hepatol Apr 2002, 14(4):413-418.
10. Linskens R.K., van Bodegraven A.A., Schoorl M., Tuynman H.A., Bartels P. Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis. Dig Dis Sci Mar 2001, 46(3):644-648.
11. Best W.R., Becktel J.M., Singleton J.W. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979, 77:843-846.
12. Chiarantini E., Valanzano R., Liotta A.A.., Cellai A.P., Fedi S., Ilari I., et al. Hemostatic abnormalities in inflammatory bowel disease. Thromb Res 1996, 82:137-146.
13. Seitz R., Leugner F., Katchinski M., Immel A., Kraus M., Egbring R., et al. Ulcerative colitis and Crohn's disease: factor XIII, inflammation and haemostasis. Digestion 1994, 55:361-367.
14. Wisen O., Gardlund B. Hemostasis in Crohn's disease: low factor XIII levels in active disease. Scand J Gastroenterol 1988, 23:961-966.
15. Van Bodegraven A.A., Tuynman H.A., Schoorl M., Kruishoop A. Fibrinolytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel disease. Scand J Gastroenterol 1995, 30:580-585.
16. Ayabe T., Ashida T., Taruishi M., Saito Y., Murakami M., Obara T., et al. Analysis of coagulation factor XIII in Crohn's disease-establishment of a novel monoclonal anti-coagulation factor XIII antibody. Nihon Shokakibyo Gakkai Zasshi 1992, 89:28-35.
17. D'Argenio G., Bianco L., Cosenza V., Della Valle N., D'Armiento F.P., Boirivant M., et al. Transglutaminases in Crohn's disease. Gut 1995, 37:690-695.
18. Hudson M., Wakefield A.J., Hutton R.A., Sankey E.A., Dhillon A.P., More L., et al. Factor XIIIA subunit and Crohn's disease. Gut 1993, 34:75-79.
19. Chiarantini E., Valanzano R., Liotta A.A., Cellai A.P., Fedi S., Ilari I., et al. Persistence of hemostatic alterations in patients affected by Crohn's disease after bowel surgery. Thromb Res 1997, 87:539-546.
20. Higaki S., Nakano K., Onaka S., Amano A., Tanioka Y., Harada K., et al. Clinical significance of measuring blood coagulation factor XIIIA regularly and continuously in patients with Crohn's disease. J Gastroenterol Hepatol 2006, 21:1407.
21. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989, 170:2-6. [discussion 16-9].
22. Thompson W.G., Longstreth G.F., Drossman D.A., Heaton K.W., Irvine E.J., Muller-Lissner S.A. Functional bowel disorders and functional abdominal pain. Gut 1999, 45(Suppl. 2):43-47. [II].
23. Oshitani N., Nakamura S., Matsumoto T., Kobayashi K., Kitano A. Treatment of Crohn's disease fistulas with coagulation factor XIII. Lancet 1996, 347:119-120.